Literature DB >> 17472588

Acute effects of methylphenidate on performance during the Test of Variables of Attention in children with attention deficit/hyperactivity disorder.

Yu-Shu Huang1, Chia-Chen Chao, Yu-Yu Wu, Yu-Ying Chen, Chih-Ken Chen.   

Abstract

This study attempted to determine the acute effects of methylphenidate (MPH) on cognitive performance using the Test of Variables of Attention (TOVA) in children with attention deficit/hyperactivity disorder (ADHD). The study subjects comprised 57 children diagnosed with ADHD aged 6-13 years. Diagnoses of ADHD and other comorbid psychiatric disorders were based on Diagnostic and Statistical Manual of Mental Disorders-fourth edition criteria following a standard interview with the Schedule for Affective Disorder and Schizophrenia for School-Age Children, epidemiologic version. The subjects' performance on the TOVA was compared before and 1 h after administration of MPH. After administration of MPH, commission scores, response time and ADHD scores improved significantly, however, there were no significant changes in omission scores, response time variability or response sensitivity. The authors concluded that administration of one dose of MPH (0.5-1.0 mg/kg) produced more effects on impulsivity than on attention deficiency in children with ADHD, and that the second half section of the TOVA could be more sensitive than the first half in determining the acute effects of MPH therapy in children with ADHD. However, the effects of different MPH doses on the TOVA results need further investigation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17472588     DOI: 10.1111/j.1440-1819.2007.01653.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  8 in total

1.  Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder.

Authors:  Sharon B Wigal; Tim Wigal; Sabrina Schuck; Matthew Brams; David Williamson; Robert B Armstrong; H Lynn Starr
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-04-13       Impact factor: 2.576

Review 2.  The clinical utility of the continuous performance test and objective measures of activity for diagnosing and monitoring ADHD in children: a systematic review.

Authors:  Charlotte L Hall; Althea Z Valentine; Madeleine J Groom; Gemma M Walker; Kapil Sayal; David Daley; Chris Hollis
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-11-30       Impact factor: 4.785

3.  Objective versus subjective assessment of methylphenidate response.

Authors:  Iris Manor; Sheera Meidad; Gil Zalsman; Zvi Zemishlany; Sam Tyano; Abraham Weizman
Journal:  Child Psychiatry Hum Dev       Date:  2007-12-05

4.  Long-term neurocognitive effects of methylphenidate in patients with attention deficit hyperactivity disorder, even at drug-free status.

Authors:  Yu-Shu Huang; Liang-Jen Wang; Chih-Ken Chen
Journal:  BMC Psychiatry       Date:  2012-11-09       Impact factor: 3.630

5.  Protocol investigating the clinical utility of an objective measure of activity and attention (QbTest) on diagnostic and treatment decision-making in children and young people with ADHD-'Assessing QbTest Utility in ADHD' (AQUA): a randomised controlled trial.

Authors:  Charlotte L Hall; Gemma M Walker; Althea Z Valentine; Boliang Guo; Catherine Kaylor-Hughes; Marilyn James; David Daley; Kapil Sayal; Chris Hollis
Journal:  BMJ Open       Date:  2014-12-01       Impact factor: 2.692

6.  Reliability and validity of neurobehavioral function on the Psychology Experimental Building Language test battery in young adults.

Authors:  Brian J Piper; Shane T Mueller; Alexander R Geerken; Kyle L Dixon; Gregory Kroliczak; Reid H J Olsen; Jeremy K Miller
Journal:  PeerJ       Date:  2015-12-22       Impact factor: 2.984

7.  The Impact of Methylphenidate on QbTest Performance of Children with ADHD: A Retrospective Clinical Study.

Authors:  Rajna Knez; Dejan Stevanovic; Salmir Nasic; Ana Doric; Elisabet Wentz
Journal:  Neuropsychiatr Dis Treat       Date:  2021-01-06       Impact factor: 2.570

8.  Reverse translation of the rodent 5C-CPT reveals that the impaired attention of people with schizophrenia is similar to scopolamine-induced deficits in mice.

Authors:  J W Young; M A Geyer; A J Rissling; R F Sharp; L T Eyler; G L Asgaard; G A Light
Journal:  Transl Psychiatry       Date:  2013-11-12       Impact factor: 6.222

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.